VREXVarex Imaging Corporation

$10.29+29% 1Y

Is the price fair?

Mixed

In its normal P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 neutral, 2 without data
Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 34.8 vs a 29.7 median over 26 quarters (+17% vs median).

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What VREX's price assumes

Varex Imaging Corporation trades at 34.8× earnings against 25.8× for the median Medical Devices name, more expensive than its own group.

34.8

Trailing P/E · Medical Devices median 25.8 · 1.35× the median: the market pays up for this one

Details›
Healthcare median P/E509 names
26.0
Medical Devices median P/E64 names
25.8
Market capitalisation
$778M
What the market has paid for these earnings: 26 quarters of its own multiple × $0.53 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$11.91
Its own P/E history, median$15.73
Its own P/E history, upper quartile$26.82
52-week range$9.32 – $18.57
Today$10.29

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.